The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model

Journal of Infectious Diseases

Volumn 180, Issue 1, 1999, Pages 203-205

  Bourne, Nigel ^a   Bernstein, David I ^a   Ireland, James ^a   Sonderfan, Andrew J ^b   Profy, Albert T ^b   Stanberry, Lawrence R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Procept Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PRO 2000; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENITAL HERPES; INFECTION PREVENTION; INTRAVAGINAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VIRUS RESISTANCE;

ADMINISTRATION, TOPICAL; ANIMALS; FEMALE; HERPES GENITALIS; MICE; NAPHTHALENESULFONATES; POLYMERS; SOLUTIONS; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 0033047793     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314853     Document Type: Article

References (16)

1. Eng TR, Butler WT, eds. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997.
2. Stein ZA. HIV prevention: the need for methods women can use. Am J Public Health 1990;80:460-2.
3. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 1996;10(Suppl 3):S43-51.
4. Kreiss J, Ngugi E, Holmes K, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992;268:477-82.
5. Niruthisard S, Roddy RE, Chutivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992; 339:1371-5.
6. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998;339:504-10.
7. Rusconi S, Moonis M, Merrill DP, et al. Napthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities. Antimicrob Agents Chemother 1996;40:234-6.
8. Profy AT, Sonderfan AJ, Bourne N, et al. PRO 2000 gel, a potential topical microbicide for HIV prevention, can block infection by other sexually transmitted disease pathogens. In: Proceedings of the 12th World AIDS Conference (Geneva, Switzerland). Bologna, Italy: Monduzzi editiore, 1998:233-7.
9. Milligan GN, Bernstein DI. Generation of humoral responses against herpes simplex virus type 2 (HSV-2) in the murine female genital tract. Virology 1995;206:234-41.
10. Stanberry LR, Bernstein DL, Burke RL, Pachl C, Myers MG. Recombinant herpes simplex virus glycoprotein vaccine protects against initial and recurrent genital herpes. J Infect Dis 1987;155:914-20.
11. Niruthisard S, Roddy RE, Chutivongse S. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991;18:176-9.
12. Stafford MK, Ward H, Flanagan A, et al. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol 1997;17:327-31.
13. Whaley KJ, Barratt RA, Zeitlin L, Hoen TE, Cone RA. Nonxynol-9 protects mice against vaginal transmission of genital herpes infections. J Infect Dis 1993;168:1009-11.
14. Lyons JM, Ito JI Jr. Reducing the risk of Chlamydia trachomatis genital tract infection by evaluating the prophylactic potential of vaginally applied chemicals. Clin Infect Dis 1995;21(Suppl 2):S174-7.
15. Zeitlin L, Whaley KJ, Hegarty TA, Moench TR, Cone RA. Tests of vaginal microbicides in the mouse genital herpes model. Contraception 1997;56: 329-35.
16. Kokuba H, Aruelian L, Neurath AR. 3-Hydroxyphtaloyl Β-lactoglobulin. IV. Antiviral activity in the mouse model of genital herpesvirus infection. Antivir Chem Chemother 1998;9:353-7.